Physician

Abhishek Swami

According to 2025 Medicare claims, Abhishek Swami (NPI: 1164637849) practices nephrology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is KIDNEY SPECIALISTS OF MICHIGAN (NPI: 1942459805; TIN: 263282229) and primary practice location at 48073-6712.

Swami's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 271 traditional Medicare patients, billed 1,216 HCPCS/CPT codes, and received $137,652 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,127 prescription claims across 152 beneficiaries totaling $289,773 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 17 claims. Open Payments data shows 49 records totaling $1,041. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $122,498 to $289,773. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	406	2,370	$199,116
2016	418	2,427	$208,497
2017	379	1,901	$203,935
2018	395	1,960	$162,039
2019	397	1,951	$167,049
2020	357	1,954	$172,760
2021	313	1,618	$142,662
2022	323	2,031	$189,334
2023	270	1,334	$147,550
2024	271	1,216	$137,652

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	79	724	$122,498
2016	107	855	$92,838
2017	103	790	$47,017
2018	96	866	$35,294
2019	119	874	$59,876
2020	115	824	$75,003
2021	127	824	$93,444
2022	132	780	$67,568
2023	156	924	$133,402
2024	152	1,127	$289,773

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	47	$1,862
2020	N/R	67	$2,544
2021	N/R	39	$1,226
2022	N/R	68	$1,271
2023	N/R	61	$1,688
2024	N/R	17	$213

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	107	117	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	141	572	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	19	20	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	37	76	$62
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	69	110	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	78	3,039	$53,856
Jardiance	Empagliflozin	53	2,160	$41,483
Veltassa	Patiromer Calcium Sorbitex	19	612	$14,398
Lokelma	Sodium Zirconium Cyclosilicate	12	432	$7,210
Sevelamer Carbonate	Sevelamer Carbonate	36	1,669	$3,783

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	17	$213

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$1,041	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhishek Swami?

Tedicare shows public-source Medicare data for Abhishek Swami (NPI 1164637849), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhishek Swami have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abhishek Swami?

Abhishek Swami is linked to KIDNEY SPECIALISTS OF MICHIGAN (billing NPI 1942459805) in the available physician profile data.

Does Abhishek Swami have Open Payments data?

Abhishek Swami has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.